Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hematology
•
Nephrology
•
Glomerulonephritis
Would you consider initiating eculizumab without plasmapheresis as initial therapy for a patient with renal TMA who has a low suspicion of TTP based on a scoring algorithm?
Frimat M, et al., PMID 39342982
Related Questions
How would you treat idiopathic isolated renal TMA diagnosed on renal biopsy without evidence of MAHA?
How do you counsel patients who are found to have a carrier mutation in a single high-risk APOL1 allele?
How long would you wait before performing a kidney biopsy in a patient with nephrotic range proteinuria, a negative PLA2R antibody, a negative anti-THSD7A antibody, and stable renal function who recently started treatment a week ago with a DOAC for a pulmonary embolism?
How would you approach management and monitoring of AL amyloidosis with isolated renal involvement?
Which clinical characteristics would prompt you to consider an oral factor B inhibitor such as iptacopan in the treatment of IgA nephropathy?
Do you wait until serum anti-GBM antibody titers are undetectable before hospital discharge in a patient with anti-GBM antibody disease with renal involvement who is receiving daily plasmapheresis, cyclophosphamide, and steroids?
How often do you check fibrinogen levels and when do you administer FFP for patients with AKI requiring plasma exchange?
How would you approach the treatment of crescentic fibrillary glomerulonephritis?
How do you decide when to stop immunosuppression in a patient with granulomatosis with polyangiitis who is on dialysis, has not yet recovered renal function, but has shown improvement in ANCA levels?
Do you routinely check serum phosphorus levels after IV iron therapy?
